Glaukos Corporation

(GKOS) Trade

By |

Profile

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Contact Information

Website: www.glaukos.com
Email: clewis@glaukos.com
Main Phone: +1 949 367-9600
Address: 229 Avenida Fabricante
Address 2: Suite 103
State: CA
City / Town: San Clemente
Country: USA
Postal Code: 92672

Issuer Information

Exchange: NYE
CEO: Thomas W. Burns
Employees: 132
NAICS: Surgical and Medical Instrument Manufacturing(339112)
$ 65.79 $ -0.5 (-0.75%)
Last Price 65.79 Change $ -0.5 Change % -0.75 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 66.50 High 67.52 Low 65.35 Prev Close 66.29
Last Trade Volume 484,872 52 Wk Hi 70.91 52 Wk Low 25.25
Market Cap 2.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,028,216.00 EPS (TTM) -0.39 PE Ratio N/A Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 41
Number of Buys 0 8
Number of Sells 1 33
Net Activity -8883 -1676812
Last 10 Buys Shares
Joseph E. Gilliam 1,000
Aimee S. Weisner 1,000
Richard L. Harrison 1,000
Thomas W. Burns 1,000
Aimee S. Weisner 1,000
Robert J. More 1,000
Last 10 Sell Shares
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
Jonathan T. Silverstein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 49 49 49 49
Low Target Price Estimate 32 32 32 32
Mean Target Price Estimate 40.71 39.29 39.29 40.71
Standard Deviation 5.41 5.82 5.82 5.41
Date of Most Recent Estimate 06/04/18 05/10/18 05/10/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 8 8 9
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.22 1.22 1